Publications Research group Krüger

31. Interleukin 6/interleukin 6 receptor interaction and its role as a therapeutic target for treatment of cachexia and cancer.
Weidle UH, Klostermann S, Eggle D, Krüger A
Cancer Genomics Proteomics. .
PMID: 21156962 [PubMed - in process]
32. A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor.
Schelter F, Kobuch J, Moss ML, Becherer JD, Comoglio PM, Boccaccio C, Krüger A
J Biol Chem. 2010 Aug 20.
PMID: 20554517 [PubMed - in process]
33. Identification of a survival-independent metastasis-enhancing role of hypoxia-inducible factor-1alpha with a hypoxia-tolerant tumor cell line.
Schelter F, Gerg M, Halbgewachs B, Schaten S, Görlach A, Schrötzlmair F, Krüger A
J Biol Chem. 2010 Aug 20.
PMID: 20566631 [PubMed - in process]
34. Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition.
Krüger A, Kates RE, Edwards DR
Biochim Biophys Acta. 2010 Jan .
PMID: 19800374 [PubMed - in process]
35. Placental expression of proteases and their inhibitors in patients with HELLP syndrome.
von Steinburg SP, Krüger A, Fischer T, Mario Schneider KT, Schmitt M
Biol Chem. 2009 Nov .
PMID: 19663680 [PubMed - in process]
36. The influence of the stable expression of BMP2 in fibrin clots on the remodelling and repair of osteochondral defects.
Vogt S, Wexel G, Tischer T, Schillinger U, Ueblacker P, Wagner B, Hensler D, Wilisch J, Geis C, Wübbenhorst D, Aigner J, Gerg M, Krüger A, Salzmann GM, Martinek V, Anton M, Plank C, Imhoff AB, Gansbacher B
Biomaterials. 2009 Apr .
PMID: 19185914 [PubMed - in process]
37. Functional genetic mouse models: promising tools for investigation of the proteolytic internet.
Krüger A
Biol Chem. 2009 Feb .
PMID: 19040350 [PubMed - in process]
38. Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liver.
Kopitz C, Gerg M, Gansbacher B, Krüger A
Hum Gene Ther. 2008 Oct .
PMID: 18681831 [PubMed - in process]
39. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice.
Vasiljeva O, Korovin M, Gajda M, Brodoefel H, Bojic L, Krüger A, Schurigt U, Sevenich L, Turk B, Peters C, Reinheckel T
Oncogene. 2008 Jul 10.
PMID: 18345026 [PubMed - in process]
40. Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma.
Zhong JL, Poghosyan Z, Pennington CJ, Scott X, Handsley MM, Warn A, Gavrilovic J, Honert K, Krüger A, Span PN, Sweep FC, Edwards DR
Mol Cancer Res. 2008 Mar .
PMID: 18296648 [PubMed - in process]